Showing results (1-10 of 72) with videos related to
Sort By:
Pageof 8
Expert Review of Clinical Pharmacology|October 5, 2021
Getting immunosuppression just right: the role of clinical biomarkers in predicting patient response post solid organ transplantationMercè Brunet, Olga MillánPharmaceutics|September 23, 2022
Insights into the Pharmacogenetics of Tacrolimus Pharmacokinetics and PharmacodynamicsMercè Brunet, Marçal Pastor-AngladaTherapeutic Drug Monitoring|November 6, 2024
miRNAs, dd-cf-DNA, and Chemokines as Potential Noninvasive Biomarkers for the Assessment of Clinical Graft Evolution and Personalized Immunosuppression Requirement in Solid Organ TransplantationOlga Millán, Judit Julian, Mercè BrunetProgress in Neuro-Psychopharmacology & Biological Psychiatry|April 21, 2026
MicroRNAs as potential biomarkers in schizophrenia: Current methodological limitations and challengesMar Hernaez, Eduard Parellada, Mercè BrunetTransplantation Reviews (Orlando, Fla.)|March 21, 2009
Biomarkers of the immunomodulatory effect of immunosuppressive drugs in transplant recipientsOlga Millán, Nerea Urtasun, Mercè BrunetPharmacogenomics|October 28, 2025
Glaucoma diagnosis and treatment in the era of precision medicineSara Labay-Tejado, Mercè Brunet, Elena MillaTherapeutic Drug Monitoring|March 19, 2019
Pharmacodynamic Monitoring of mTOR InhibitorsOlga Millán, Eberhard Wieland, Pierre Marquet, et al.Therapeutic Drug Monitoring|October 8, 2015
T-Cell Cytokines as Predictive Markers of the Risk of Allograft RejectionMercè Brunet, Olga Millán López, Marcos López-HoyosAdvances in Laboratory Medicine|December 18, 2023
Influence of pharmacogenetics on the diversity of response to statins associated with adverse drug reactionsJaime I Sainz de Medrano Sainz, Mercè Brunet SerraEnfermedades Infecciosas Y Microbiologia Clinica|May 1, 2012
Antimicrobial and immunosuppressive drug interactions in solid organ transplant recipientsSoledad Berdaguer, Javier Bautista, Mercè Brunet, et al.Pageof 8